Indeed, all previously published studies supported the notion by demonstrating that ARHGAP15 functioned as a tumor suppressor in lung cancer [14], breast cancer [15], colon cancer [16] and glioma [17]. Here, ARHGAP15 is linked to central nervous system cancer.